T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $935B
1-Year Est. Return 30.3%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Est. Return
1 Year Est. Return
+30.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$883B
AUM Growth
+$71.2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,193
New
Increased
Reduced
Closed

Top Buys

1 +$4.95B
2 +$3.48B
3 +$2.66B
4
AMD icon
Advanced Micro Devices
AMD
+$1.92B
5
GE icon
GE Aerospace
GE
+$1.49B

Top Sells

1 +$3.79B
2 +$2.63B
3 +$2.46B
4
FISV
Fiserv Inc
FISV
+$2.19B
5
LLY icon
Eli Lilly
LLY
+$1.78B

Sector Composition

1 Technology 34.76%
2 Financials 12.08%
3 Healthcare 10.97%
4 Consumer Discretionary 10.95%
5 Communication Services 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
351
Altria Group
MO
$97.7B
$301M 0.03%
5,131,837
+124,329
RMBS icon
352
Rambus
RMBS
$11.3B
$300M 0.03%
4,693,390
-4,053,466
FE icon
353
FirstEnergy
FE
$25.9B
$300M 0.03%
7,443,360
+4,857
KYMR icon
354
Kymera Therapeutics
KYMR
$6.25B
$299M 0.03%
6,859,202
+156,752
ST icon
355
Sensata Technologies
ST
$5.01B
$299M 0.03%
9,913,988
+949,911
SSNC icon
356
SS&C Technologies
SSNC
$21.1B
$298M 0.03%
3,600,906
+6,052
TTC icon
357
Toro Company
TTC
$6.82B
$295M 0.03%
4,170,296
-2,203,796
BKR icon
358
Baker Hughes
BKR
$47.1B
$294M 0.03%
7,678,030
-3,502,071
CUBE icon
359
CubeSmart
CUBE
$8.11B
$293M 0.03%
6,891,469
+56,514
SLNO icon
360
Soleno Therapeutics
SLNO
$2.69B
$290M 0.03%
3,461,482
+1,061,064
CAVA icon
361
CAVA Group
CAVA
$6.14B
$288M 0.03%
3,421,966
+1,027,405
THG icon
362
Hanover Insurance
THG
$6.37B
$288M 0.03%
1,695,528
+412,133
IDXX icon
363
Idexx Laboratories
IDXX
$55.8B
$288M 0.03%
536,101
-1,452,811
ALKS icon
364
Alkermes
ALKS
$4.7B
$287M 0.03%
10,041,900
-1,746,345
CDW icon
365
CDW
CDW
$19.2B
$287M 0.03%
1,608,503
-23,616
IBN icon
366
ICICI Bank
IBN
$109B
$287M 0.03%
8,522,903
+158,007
CON
367
Concentra Group Holdings
CON
$2.49B
$286M 0.03%
13,905,380
-816,946
QGEN icon
368
Qiagen
QGEN
$9.88B
$285M 0.03%
5,936,065
+1,465,337
FWONK icon
369
Liberty Media Series C
FWONK
$23.1B
$279M 0.03%
2,666,653
+942,435
PAC icon
370
Grupo Aeroportuario del Pacifico
PAC
$12.1B
$277M 0.03%
1,204,398
+102,465
LYV icon
371
Live Nation Entertainment
LYV
$32.3B
$276M 0.03%
1,821,792
+232,809
CCJ icon
372
Cameco
CCJ
$40.6B
$275M 0.03%
3,710,464
+1,024,164
CAH icon
373
Cardinal Health
CAH
$47B
$274M 0.03%
1,630,920
-23,116
RCL icon
374
Royal Caribbean
RCL
$67.7B
$274M 0.03%
874,191
-450,815
PFE icon
375
Pfizer
PFE
$144B
$273M 0.03%
11,252,439
-10,363,057